Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00056901 · ClinicalTrials.gov registry record

Screening Evaluation for Women With Postpartum Depression

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Terminated
Registry status
68
Enrollment target

NCT00056901 is a clinical trial that was terminated before completion, run by National Institute of Mental Health (NIMH). The registered enrollment target is 68 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00056901 was terminated before completion, sponsored by National Institute of Mental Health (NIMH).

TERMINATED
Registry status
68 participants
Enrollment target

Study Summary

This study evaluates the relationship between mood changes and hormones in women with postpartum depression (PPD). This is an observational study; volunteers who participate will not receive any new or experimental therapies. PPD is similar to major depression, but develops around the time a woman gives birth. Women with PPD often suffer serious physical and emotional impairments. Controversy exists regarding the role of hormone changes in postpartum depression. This study will examine the role of hormone changes in three groups of women: those who recently gave birth and have mild to moderately severe PDD (Group 1), women who recently gave birth and do not have PDD (Group 2), and those who are currently pregnant and experienced an episode of PDD with a previous birth (Group 3). Participants will be screened with a medical history, physical examination, and blood and urine tests. Upon study entry, they will be interviewed about their moods, behaviors, and medical status during and immediately following their last pregnancy. Some women will be asked to participate in interviews, psychological tests, and blood tests. They will also complete self-rating scales and may be asked to collect samples of their urine. Women in Group 3 will complete self-rating scales for 6 months postpartum. Participants will participate in genetic studies that involve completing a questionnaire and providing a blood sample. If the participant allows, sisters and parents may be asked to provide a blood sample and undergo a psychiatric interview. Participants who meet the criteria for minor depression or major depression that is no greater than moderate severity will be asked to participate in a companion study that will evaluate the effectiveness of estradiol in reducing depression symptoms. ...

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2003-03-25
Est. Completion 2017-12-24

What the Registry Record Tells You About NCT00056901

The ClinicalTrials.gov registry entry for NCT00056901 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00056901 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00056901 about?

NCT00056901 is a clinical study titled "Screening Evaluation for Women With Postpartum Depression". This study evaluates the relationship between mood changes and hormones in women with postpartum depression (PPD). This is an observational study; volunteers who participate will not receive any new or experimental therapies. PPD is similar to major depression, but develops around the time a woman...

What is the current status of trial NCT00056901?

This trial is currently terminated. The enrollment target is 68 participants. The study started on 2003-03-25. Estimated completion is 2017-12-24.

Who is sponsoring clinical trial NCT00056901?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.